← 返回

仿生淋巴结样支架用于优化 CAR-T 细胞扩增并增强抗肿瘤疗效

英文原题:Biomimetic lymph node-like scaffolds for optimized CAR-T cell expansion and potentiated antitumor efficacy.

查看英文原题

Biomimetic lymph node-like scaffolds for optimized CAR-T cell expansion and potentiated antitumor efficacy.

PubMed 2025/09/24(内容时间) J Mater Chem B Q2 · IF 6.2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

CAR-T 细胞疗法在治疗血液系统恶性肿瘤方面展现出显著前景。然而,CAR-T 细胞的体外扩增耗时较长,可能损害其功能。生理条件下,T细胞在淋巴结(LN)副皮质区活化和增殖;该动态环境由三维(3D)网状网络(RN)构成,可促进细胞迁移和介质递送。模拟这一生理微环境为改善CAR-T 细胞扩增提供了有吸引力的策略。受RN结构启发,我们开发了仿生RN样多孔微球(PM),建立适用于T细胞和CAR-T 细胞增殖的三维培养平台。与传统方法相比,该工程化系统显著提高了人T细胞和CAR-T 细胞的增殖率,同时保留了较高比例的中央记忆T细胞(TCM),并降低耗竭标志物(PD-1、TIM-3和LAG-3)的表达。

此外,在PM中扩增的CAR-T 细胞在离体和体内模型中均展现出更强的抗肿瘤效力,这与RNA水平上富集了稳健T细胞功能相关通路相一致。

总体而言,这一仿生平台解决了人T/CAR-T 细胞扩增中的关键局限,有助于维持细胞功能并改善治疗结局。

展开英文摘要原文

Chimeric antigen receptor T cell (CAR-T) therapy has shown remarkable promise in treating hematological malignancies.

However, the ex vivo expansion of CAR-T cells is time-consuming, potentially impairing CAR-T cell function. Physiologically, T cell activation and proliferation occur within the lymph node (LN) paracortex, a dynamic environment structured by a three-dimensional (3D) reticular network (RN) that promotes cell migration and mediator delivery. Mimicking this physiological niche offers a compelling strategy to improve CAR-T cell expansion.

Inspired by the structure of the RN, we developed a biomimetic RN-like poriferous microsphere (PM) to establish a 3D culture platform optimized for both T cell and CAR-T cell proliferation. This engineered system not only significantly enhanced the proliferation rates of human T cells and CAR-T cells compared to conventional methods, but also preserved a higher proportion of central memory T cells (T CM ) and reduced the expression of exhaustion markers (PD-1, TIM-3, and LAG-3).

Moreover, CAR-T cells expanded in PMs exhibited superior anti-tumor efficacy in both ex vivo and in vivo models, which correlated with the enrichment of pathways associated with robust T cell function at the RNA level.

Overall, this biomimetic platform addresses critical limitations in human T/CAR-T cell expansion, preserving cell function and improving therapeutic outcomes.

论文信息

作者
Zhang H、Liu F、Zhao J、Wang Y、Shen Y、Li Q、Luo H、Chen Y
单位
State Key Laboratory of Biotherapy and Cancer center, West China Hospital, Sichuan University, Chengdu, China. yhansh@scu.edu.cn.China
期刊
Journal of materials chemistry. B2025 Sep 24
原文标识
PubMed 40878229 · DOI 10.1039/d5tb01594d